Soleus Capital Management »

Arcus Biosciences Incorporated shares owned by Soleus Capital Management

Quarter-by-quarter ownership of Arcus Biosciences Incorporated (RCUS) shares owned by Soleus Capital Management from 13F filings

Historical chart of Soleus Capital Management investment in Arcus Biosciences Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Arcus Biosciences Incorporated held by Soleus Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcus Biosciences Incorporated by Soleus Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $17M 712k 23.83

More positions owned by Soleus Capital Management

Spdr Series Trust State Street Spd Put Option (XBI)
Krystal Biotech (KRYS)
Celcuity (CELC)
Novocure Ord Shs (NVCR)
Praxis Precision Medicines I Com New (PRAX)
Tg Therapeutics (TGTX)
Dex (DXCM)
BioMarin Pharmaceutical (BMRN)
Globus Med Cl A (GMED)
Beta Bionics (BBNX)
Amicus Therapeutics (FOLD)
Twist Bioscience Corp (TWST)
Organogenesis Hldgs (ORGO)
Syndax Pharmaceuticals (SNDX)
Mirum Pharmaceuticals (MIRM)

View all positions for Soleus Capital Management

Top funds holding Arcus Biosciences Incorporated

Gilead Sciences
BlackRock
Vanguard Group
Suvretta Capital Management
State Street Corporation
Woodline Partners
Marshall Wace
Point72 Asset Management
Siren
FMR
Fisher Investments
Caption Management
Geode Capital Management
Balyasny Asset Management
Bnp Paribas Investment Partners

View all funds holding Arcus Biosciences Incorporated